D. E. Shaw & Co., Inc. Beyond Air, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.96 - $7.83 $321,145 - $506,969	-64,747 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.33 - $9.53 $36,289 - $54,635	-5,733 Reduced 8.13%	64,747 $433,000
Q4 2021 Feb 14, 2022	BUY	$8.44 - $15.61 $594,851 - $1.1 Million	70,480 New	70,480 $665,000
Q3 2021 Nov 15, 2021	SELL	$5.9 - $12.54 $145,564 - $309,386	-24,672 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.72 - $7.15 $116,451 - $176,404	24,672 New	24,672 $160,000

11.1M

54.4K

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $17M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.